Alexander Clayton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexander Clayton has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hoiwan Cheung
Department of Radiology, Division Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98195, USA
1 shared publication - Jafar Golzarian
Department of Radiology, University of Minnesota and NorthStar Vascular & Interventional, Minneapolis, USA
1 shared publication - Majid Chalian
Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, UW Radiology-Roosevelt Clinic, Seattle, USA
1 shared publication - Pooya Torkian
Vascular and Interventional Radiology, Department of Radiology, University of Minnesota, Minneapolis, MN, USA
1 shared publication - Reza Talaie
Vascular and Interventional Radiology, Department of Radiology, University of Minnesota, Minneapolis, USA
1 shared publication - Stephanie Wallace
Vascular and Interventional Radiology, Department of Radiology, University of Minnesota, Minneapolis, MN 55455, USA
1 shared publication
Latest Publications
- Open Access
- 6 June 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (6) , 1403
Emerging Targets for the Treatment of Osteoarthritis: New Investigational Methods to Identify Neo-Vessels as Possible Targets for Embolization
Osteoarthritis (OA) is the major cause of disability, affecting over 30 million US adults. Continued research into the role of neovascularization and inflammation related to osteoarthritis in large-animal models and human clinical trials is paramount. Recent literature on the pathogenetic model of OA has refocused on low-level inflammation, resulting in joint remodeling. As a result, this has redirected osteoarthritis research toward limiting or treating joint changes associated with persistent synovitis. The overall goal of this review is to better understand the cellular and tissue-specific mechanisms of inflammation in relation to a novel OA treatment modality, Genicular Artery Embolization (GAE). This article also assesses the utility and mechanism of periarticular neovascular embolization for the treatment of OA with a particular emphasis on the balance between pro-angiogenic and anti-angiogenic cytokines, inflammatory biomarkers, and imaging changes.
- 6 June 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (6) , 1403
Open AccessEmerging Targets for the Treatment of Osteoarthritis: New Investigational Methods to Identify Neo-Vessels as Possible Targets for Embolization
Osteoarthritis (OA) is the major cause of disability, affecting over 30 million US adults. Continued research into the role of neovascularization and inflammation related to osteoarthritis in large-animal models and human clinical trials is paramount. Recent literature on the pathogenetic model of OA has refocused on low-level inflammation, resulting in joint remodeling. As a result, this has redirected osteoarthritis research toward limiting or treating joint changes associated with persistent synovitis. The overall goal of this review is to better understand the cellular and tissue-specific mechanisms of inflammation in relation to a novel OA treatment modality, Genicular Artery Embolization (GAE). This article also assesses the utility and mechanism of periarticular neovascular embolization for the treatment of OA with a particular emphasis on the balance between pro-angiogenic and anti-angiogenic cytokines, inflammatory biomarkers, and imaging changes.